This inventor holds 2 USPTO granted patents. Top assignee: Gruppo Lepetit. Active years: 1999-2003.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Sesto San Giovanni, IT (1999)
- Sesto S. Giovanni, IT (2003)
Company Filing History:
Years Active: 1999-2003
Title: Adolfo Soffientini: Innovator in Protein Purification
Introduction
Adolfo Soffientini is a notable inventor based in Sesto S. Giovanni, Italy. He has made significant contributions to the field of protein purification, holding 2 patents that showcase his innovative approaches.
Latest Patents
His latest patents include a process for the purification of human interleukin-1 receptor antagonist from recombinant E. coli. This process involves loading a buffered mixture onto a cationic exchange matrix and eluting it with an aqueous buffered solution. The method ensures the recovery of the desired IL-1ra protein efficiently. Another patent focuses on a simple and effective process for recovering a biologically active glycoprotein from a biological fluid, further demonstrating his expertise in protein purification techniques.
Career Highlights
Adolfo Soffientini is associated with Gruppo Lepetit S.p.a., where he has applied his knowledge and skills in the field of biotechnology. His work has contributed to advancements in the purification processes that are crucial for various applications in medicine and research.
Collaborations
He has collaborated with notable coworkers such as Dino Zanette and Edoardo Giacomo Sarubbi, enhancing the innovative efforts within his team.
Conclusion
Adolfo Soffientini's contributions to protein purification highlight his role as an influential inventor in the biotechnology sector. His patents reflect a commitment to advancing scientific knowledge and improving purification processes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile